Renaissance Technologies - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 133 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,902
-21.6%
4,889,500
-10.1%
0.00%0.0%
Q2 2023$2,427
+12.1%
5,436,281
+105.9%
0.00%0.0%
Q1 2023$2,165
-46.1%
2,640,300
+2.6%
0.00%
-40.0%
Q4 2022$4,013
-99.9%
2,572,500
+10.7%
0.01%
-16.7%
Q3 2022$4,008,000
+46.9%
2,323,700
+47.3%
0.01%
+100.0%
Q2 2022$2,729,000
+93.0%
1,577,500
+300.5%
0.00%
+50.0%
Q1 2022$1,414,000
-68.5%
393,881
-34.7%
0.00%
-50.0%
Q1 2020$4,487,000
+278.3%
603,123
+67.8%
0.00%
+300.0%
Q4 2019$1,186,000
+328.2%
359,500
+166.5%
0.00%
Q3 2019$277,000
-56.1%
134,900
-37.2%
0.00%
-100.0%
Q2 2019$631,000
-70.0%
214,681
-62.0%
0.00%
-50.0%
Q1 2019$2,105,000
+57.0%
564,281
+68.3%
0.00%
+100.0%
Q4 2018$1,341,000
-35.7%
335,281
-10.7%
0.00%
-50.0%
Q3 2018$2,087,000
-27.3%
375,381
-43.2%
0.00%0.0%
Q2 2018$2,869,000
+74.2%
661,462
+89.1%
0.00%0.0%
Q1 2018$1,647,000
+9.6%
349,781
-3.9%
0.00%0.0%
Q4 2017$1,503,000
-43.0%
363,981
-7.3%
0.00%
-66.7%
Q4 2015$2,639,000392,7810.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
CAXTON ASSOCIATES LP 784,679$643,4370.10%
Green Alpha Advisors, LLC 146,300$119,9660.08%
Virtus ETF Advisers LLC 54,106$44,3670.02%
Cedar Brook Financial Partners, LLC 104,881$86,0020.02%
PROFUND ADVISORS LLC 418,749$343,3740.02%
Arlington Capital Management, Inc. 27,735$22,7430.02%
Hennion & Walsh Asset Management, Inc. 382,158$3130.02%
Rafferty Asset Management, LLC 2,647,927$2,171,3000.02%
Brainard Capital Management LLC 16,666$13,6660.01%
Beck Bode, LLC 41,218$33,7990.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders